Australia’s medicine safety officials have warned the government they are flying blind on the use of puberty blocker drugs for gender-distressed minors.
One of the scariest moments of my life happened in 2022 when my father, Tom Donvito, then 75 and unaware of any allergies, experienced an anaphylactic reaction to a hornet sting. After he passed ...
Belfast News Letter on MSN
UUP defends puberty blocker trial for 'very small number' of children - saying it was necessary to secure a ban on the drugs
The Ulster Unionist Party has backed Mike Nesbitt over plans to include Northern Irish children in a controversial national trial of puberty blocker drugs – despite its new leader Jon Burrows having ...
The Christian Post on MSN
Northern Ireland halts puberty blocker trial, cites legal challenges
The Christian Institute has welcomed news that Northern Ireland has suspended its involvement in a controversial puberty ...
Controversial NHS transgender teens puberty blocker trial is put on hold due to ‘wellbeing concerns’
THE NHS’ trial of puberty blockers for teenagers who think they are transgender has been put on hold at the last minute.
A trial of puberty blockers for children will be paused following concerns from the healthcare regulator. The Medicines and Healthcare products Regulatory Agency (MHRA) has stepped in amid a growing ...
Early in 2026, Polyrizon Ltd. (Nasdaq: PLRZ), a pre-clinical-stage biotechnology company developing intranasal protective solutions, completed the branding process for its lead intranasal allergy ...
Children are being paid to take part in an NHS puberty blocker trial, The Telegraph can reveal. Some 226 children who believe they are transgender will be given puberty blockers as part of an ...
The Health Minister, Mike Nesbitt, recently suspended Northern Ireland’s involvement in a clinical trial of puberty blocking ...
Researchers report that pairing two known medicines reduced liver fibrosis in mice, offering a possible path toward scar ...
A new study from the University of Bologna has raised questions about a widely used type of blood pressure medicine called ...
The letter from the Medicines and Healthcare products Regulatory Agency (MHRA) highlighted concerns including the “very ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results